Prohance Multipack

BRISTOL-MEYERS SQUIBB PHARMACEUTICAL GROUP -- PROHANCE FOR INJECTION -- 6505-01-371-4206
=====================  Product Identification  =====================

Product ID:PROHANCE FOR INJECTION
MSDS Date:01/20/1994
FSC:6505
NIIN:01-371-4206
Status Code:A
MSDS Number: CKLJG
=== Responsible Party ===
Company Name:BRISTOL-MEYERS SQUIBB PHARMACEUTICAL GROUP
Box:191
City:NEW BRUNSWICK
State:NJ
ZIP:08903
Country:US
Info Phone Num:908-519-3843
Emergency Phone Num:908-519-3843
Chemtrec Ind/Phone:(800)424-9300
CAGE:TO591
=== Contractor Identification ===
Company Name:BRISTOL-MEYERS SQUIBB PHARMACEUTICAL GROUP
Box:191
City:NEW BRUNSWICK
State:NJ
ZIP:08903
Country:US
Phone:908-519-3843
CAGE:TO591

=============  Composition/Information on Ingredients  =============

Ingred Name:GADOTERIDOL
CAS:120066-54-8
= Wt:24.

Ingred Name:WATER
CAS:7732-18-5
RTECS #:ZC0110000

Ingred Name:TROMETHAMINE
CAS:77-86-1
RTECS #:TY2900000
< Wt:1.

Ingred Name:CALTERIDOL CALCIUM
CAS:121915-83-1
< Wt:1.

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:LD50 (RAT) > 5,880 MG/KG
Routes of Entry: Inhalation:NO	Skin:NO  Ingestion:NO
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:UNDER NORMAL CONDITIONS, THIS PRODUCT
    IS CONTAINED WITHIN VIALS AND SKIN/EYE CONTACT OR INHALATION WOULD
    NOT BE EXPECTED.  PROHANCE FOR INJECTION CONTAINS GADOTERIDOL, A
    CONTRAST AGENT IN MAGNETIC RES ONANCE IMAGING (MRI) INTENDED FOR
    INTRAVENOUS INJECTION, UNDER THE CARE OF A PHYSICIAN. WHEN
    ADMINISTERED PROPERLY, THIS PRODUCT CAN BE USED TO VISUALIZE SUBTLE
    BRAIN LESIONS. NAUSEA AND TASTE CHANGES  WERE REPORTED IN 1.4% OF
    PATIENTS RECEIVING THIS INJECTION.	ADVERSE CARDIOVASCULAR,
    DIGESTIVE, NERVOUS SYSTEM, RESPIRATORY, DERMAL AND AUDITORY EFFECTS
    WERE EXPERIENCED BY LESS THAN 1% OF PATIENTS.
Explanation of Carcinogenicity:NONE KNOWN.
Effects of Overexposure:NO INFORMATION.
Medical Cond Aggravated by Exposure:N/P.

=======================  First Aid Measures  =======================

First Aid:INGEST: SEEK MEDICAL ATTENTION IMMEDIATELY. INDUCTION OF
    VOMITING SHOULD BE CONSIDERED FOR SIGNIFICANT INGESTION IF PERSON
    IS CONSCIOUS AND NOT EXPERIENCING CONVULSIONS. NEVER GIVE ANYTHING
    BY MOUTH T O AN UNCONSCIOUS PERSON. INHALE: REMOVE TO FRESH AIR. IF
    PERSON IS NOT BREATHING GIVE ARTIFICIAL RESPIRATION. IF BREATHING
    IS DIFFICULT ADMINISTER OXYGEN. SKIN: WASH WITH SOAP AND WATER. GET
    MEDICAL A TTENTION IF IRRITATION  DEVELOPS AND PERSISTS. EYE: HOLD
    EYELIDS APART AND FLUSH WITH RUNNING WATER FOR AT LEAST 15 MINUTES.
    GET MEDICAL ATTENTION IMMEDIATELY.

=====================  Fire Fighting Measures  =====================

Extinguishing Media:UNLIKELY TO BURN IN VIAL. IN CASE OF FIRE, FLOOD
    WITH WATER.
Fire Fighting Procedures:FIREFIGHTERS SHOULD WEAR SELF-CONTAINED
    BREATHING APPARATUS, FLAME AND CHEMICAL RESISTANT CLOTHING, BOOTS
    AND GLOVES. EVACUATE WITH WATER FROM A MAXIMUM DISTANCE.
Unusual Fire/Explosion Hazard:NONE KNOWN.

==================  Accidental Release Measures  ==================

Spill Release Procedures:ABSORB SPILL WITH INERT MATERIAL, E.G., SAND, 
    VERMICULITE OR OTHER NON-COMBUSTIBLE ABSORBENT MATERIALS, AND PLACE
    INTO A CLOSED CONTAINER FOR RECLAMATION OR DISPOSAL. FLUSH RESIDUAL
    SPILL AREA WITH W ATER TO PROCESS SEWER IF ALLOWABLE UNDER
    NATIONAL, STATE, OR LOCAL PERMITS OR REGULATIONS.

======================	Handling and Storage  ======================

Handling and Storage Precautions:DO NOT BREAK VIALS. AVOID SKIN AND EYE
    CONTACT. SHOULD BE STORED AT CONTROLLED ROOM TEMPERATURES (15 - 30
    DEGREE C). DO NOT FREEZE.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:WHEN ENGINEERING CONTROLS ARE NOT SUFFICIENT TO
    CONTROL EXPOSURE, WEAR APPROVED RESPIRATORY PROTECTION APPROPRIATE
    FOR EXPOSURE POTENTIAL; SELF-CONTAINED BREATHING APPARATUS SHOULD
    BE AVAILABLE FOR EM ERGENCY USE.
Ventilation:NONE BEYOND GOOD ROOM VENTILATION NORMALLY REQUIRED.
Protective Gloves:IMPERVIOUS GLOVES.
Eye Protection:SAFETY GLASSES.
Other Protective Equipment:WEAR PROTECTIVE OVERALLS WHENEVER THE
    POTENTIAL FOR SEVERE DUSTY CONDITIONS OR SPLASHING AND SPRAYING
    LIQUIDS EXISTS.
Work Hygienic Practices:WASH HANDS AFTER HANDLING COMPOUNDS AND BEFORE
    EATING, SMOKING, USING LAVATORY, AND AT THE END OF THE DAY.
Supplemental Safety and Health

==================  Physical/Chemical Properties  ==================

HCC:N1
Boiling Pt:=100.C, 212.F
Melt/Freeze Pt:=0.C, 32.F
Spec Gravity:1.14
Evaporation Rate & Reference:SAME AS WATER
Solubility in Water:ABOUT 620 MG/ML
Appearance and Odor:CLEAR, COLORLESS TO SLIGHTLY YELLOW AQUEOUS LIQUID
    WHICK IS PACKAGED IN VIALS.

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
ACIDS.
Stability Condition to Avoid:WHEN STORED AT CONTROLLED ROOM
    TEMPERATURES (15-30 DEGREE C) IN ORIGINAL CONTAINER, MATERIAL IS
    STABLE TO EXPIRATION DATE SHOWN ON PRODUCT LABEL.
Hazardous Decomposition Products:OXIDES OF CARBON, AND OXIDES OF
    NITROGEN.

===================  Toxicological Information	===================

Toxicological Information:IN LABORATORY ANIMALS, GADOTERIDOL WAS
    ESSENTIALLY NONTOXIC WHEN ADMINISTERED BY THE INTRAVENOUS ROUTE. AT
    DOSES, APPROXIMATELY 100 TIMES GREATER THAN THE CLINICAL DOSE,
    EXPERIMENTAL ANIMALS EXHIBITED  ATAXIA, CONVULSIONS, COLLAPSE,
    IRREGULAR RESPIRATION.  NO TREATMENT-RELATED PATHOLOGIC CHANGES
    WERE SEEN IN SURVIVING ANIMALS.

=====================  Ecological Information  =====================

Ecological:DAPHNIA ACUTE TOXICITY (EC50) > 920 MG/L. CHEMICAL FATE
    INFORMATION: HALF-LIFE 9HYDROLYSIS): < 10% HYDROLYSIS AFTER 5 DAYS
    AT 50 DEGREES C AT ALL PH LEVELS TESTED; CONSIDERED HYDROLYTICALLY
    STABLE. AE ROBIC BIODEGRADATION: HALF-LIFE DETERMINED TO BE GREATER
    THAN 28 DAYS.

====================  Disposal Considerations  ====================

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH NATIONAL, STATE,
    LOCAL OR APPLICABLE COUNTRY REGULATIONS.

===================  MSDS Transport Information  ===================

Transport Information:DOT: NOT REGULATED.

=====================  Regulatory Information  =====================

SARA Title III Information:NONE NOTES
Federal Regulatory Information:NONE NOTED

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.